Precursor compounds for providing retinoids of the vitamin a5 pathway and uses thereof

Patent number:

WO2018091937

No items found.

The invention relates to the field of retinoid X receptor (RXR) signalling and a novel vitamin A pathway called Vitamin A5 pathway. Compounds which are useful to provide (R) 9-cis-13,14-dihydro-retinoic acid an endogenous RXR ligand are claimed as well as their uses and method for preparation thereof. The compounds of the invention are useful for pharmaceutical and nutritional uses.

Countries:

Spain

Regions:

Galicia

Centers:

UNIVERSIDAD DE VIGO, DE STRASBOURG UNIV

Other entities:

University of Debrecen; Universite de Strasbourg; Debreceni Egyetem

Sectors:

Health

Subsectors:

Biotechnology

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

The invention relates to the field of retinoid X receptor (RXR) signalling and a novel vitamin A pathway called Vitamin A5 pathway. Compounds which are useful to provide (R) 9-cis-13, 14-dihydro-retinoic acid an endogenous RXR ligand are claimed as well as their uses and method for preparation thereof. The compounds of the invention are useful for pharmaceutical and nutritional uses.

Comments

Other related patents

Health

Food & Agro

Biocidal material effective againts airbone pathogens

Countries

Spain

Health

HYDROGELS FOR THE PRODUCTION OF ARTIFICIAL TISSUE WITH ENHANCED MECHANICAL PROPERTIES

Countries

Spain

Health

Use of telomerase reverse transcriptase for treatment of conditions associated with myocardial infarction

Countries

Spain

Get back to patents directory